LFCR
Price
$7.15
Change
+$0.34 (+4.99%)
Updated
Sep 26, 01:15 PM (EDT)
Capitalization
255.15M
6 days until earnings call
SBFM
Price
$1.52
Change
-$0.04 (-2.56%)
Updated
Sep 25 closing price
Capitalization
6.93M
46 days until earnings call
Interact to see
Advertisement

LFCR vs SBFM

Header iconLFCR vs SBFM Comparison
Open Charts LFCR vs SBFMBanner chart's image
Lifecore Biomedical
Price$7.15
Change+$0.34 (+4.99%)
Volume$300
Capitalization255.15M
Sunshine Biopharma
Price$1.52
Change-$0.04 (-2.56%)
Volume$72.88K
Capitalization6.93M
LFCR vs SBFM Comparison Chart in %
Loading...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LFCR vs. SBFM commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a StrongBuy and SBFM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (LFCR: $6.81 vs. SBFM: $1.52)
Brand notoriety: LFCR and SBFM are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 185% vs. SBFM: 143%
Market capitalization -- LFCR: $255.15M vs. SBFM: $6.93M
LFCR [@Pharmaceuticals: Generic] is valued at $255.15M. SBFM’s [@Pharmaceuticals: Generic] market capitalization is $6.93M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, both LFCR and SBFM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 4 TA indicator(s) are bullish while SBFM’s TA Score has 5 bullish TA indicator(s).

  • LFCR’s TA Score: 4 bullish, 5 bearish.
  • SBFM’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SBFM is a better buy in the short-term than LFCR.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -14.12% price change this week, while SBFM (@Pharmaceuticals: Generic) price change was +3.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

SBFM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($255M) has a higher market cap than SBFM($6.93M). LFCR has higher P/E ratio than SBFM: LFCR (51.23) vs SBFM (0.00). LFCR YTD gains are higher at: -8.345 vs. SBFM (-49.333). SBFM has higher annual earnings (EBITDA): -6.19M vs. LFCR (-8.81M). SBFM has more cash in the bank: 10.3M vs. LFCR (8.27M). SBFM has less debt than LFCR: SBFM (929K) vs LFCR (131M). LFCR has higher revenues than SBFM: LFCR (129M) vs SBFM (36.3M).
LFCRSBFMLFCR / SBFM
Capitalization255M6.93M3,682%
EBITDA-8.81M-6.19M142%
Gain YTD-8.345-49.33317%
P/E Ratio51.230.005,087,465%
Revenue129M36.3M355%
Total Cash8.27M10.3M80%
Total Debt131M929K14,101%
FUNDAMENTALS RATINGS
LFCR vs SBFM: Fundamental Ratings
LFCR
SBFM
OUTLOOK RATING
1..100
216
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
5961
P/E GROWTH RATING
1..100
684
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (40) in the null industry is somewhat better than the same rating for LFCR (99) in the Industrial Specialties industry. This means that SBFM’s stock grew somewhat faster than LFCR’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that SBFM’s stock grew similarly to LFCR’s over the last 12 months.

SBFM's SMR Rating (96) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that SBFM’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (59) in the Industrial Specialties industry is in the same range as SBFM (61) in the null industry. This means that LFCR’s stock grew similarly to SBFM’s over the last 12 months.

LFCR's P/E Growth Rating (6) in the Industrial Specialties industry is significantly better than the same rating for SBFM (84) in the null industry. This means that LFCR’s stock grew significantly faster than SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRSBFM
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DUOL313.4912.32
+4.09%
Duolingo
AQB1.65-0.04
-2.37%
AquaBounty Technologies
ASIX19.09-0.52
-2.65%
AdvanSix
CPRX19.13-0.57
-2.89%
Catalyst Pharmaceuticals
LIDR2.39-0.09
-3.63%
AEye

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-3.47%
NBIX - LFCR
36%
Loosely correlated
-3.94%
SHPH - LFCR
31%
Poorly correlated
-6.22%
AMRX - LFCR
30%
Poorly correlated
-1.13%
ALKS - LFCR
29%
Poorly correlated
-2.45%
PBH - LFCR
28%
Poorly correlated
-0.84%
More

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and ELAN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-2.56%
ELAN - SBFM
28%
Poorly correlated
+0.91%
TLRY - SBFM
27%
Poorly correlated
-5.56%
LFCR - SBFM
25%
Poorly correlated
-3.47%
CGC - SBFM
25%
Poorly correlated
-3.52%
ACB - SBFM
24%
Poorly correlated
-4.44%
More